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Richard John Warrington1* and Paul Kevin Keith2The Canadian Society of Allergy & Clinical Immunology,
founded in 1945, published its first Journal in 1996, as
the Canadian Journal of Allergy & Clinical Immunology,
under the Editorship of Dr Gordon Sussman. It was a
hard copy journal containing mostly solicited manu-
scripts and its circulation was limited primarily to Soci-
ety members. In 2004, Allergy, Asthma & Clinical
Immunology (AACI) was founded, and was published by
BC Decker from that year until 2009. In 2009, a decision
was made to change to an electronic format and the
Journal joined BioMed Central.
It is interesting to note that a number of our most
accessed papers were originally submitted to the hard
copy version of the Journal produced by BC Decker (see
Table 1). These articles became generally available be-
cause of Open Access with BioMed Central. This dem-
onstrates the importance of the Open Access system for
the dissemination of medical and scientific information,
for at its peak, the hard copy of AACI never had more
than a few hundred subscribers, compared to the 20,000
to 35,000 accesses to the articles when they transferred
to an electronic format.
Since joining BioMed Central, under the Editorships
of Drs. Warrington, Kim & Watson, Allergy Asthma &
Clinical Immunology has been indexed on PubMed,
PubMed Central, Science Citation Index Expanded,
Current Contents, & Scopus. AACI has been tracked by
Thompson-Reuters for an Impact Factor since early
2014, and had an unofficial 2013 impact factor of 1.57.
The Scopus Journal Rank (SJR) has increased progres-
sively since 2009 from 0.1 to 0.5-0.6 in 2013 and the
Source Normalized Impact per paper (SNIP) has in-
creased from <0.1 to >0.8.
The number of manuscript publications has also in-
creased progressively since 2010 from 33 in that year to* Correspondence: rwarrington@hsc.mb.ca
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article, unless otherwise stated.50 in 2013, the number in 2014 was at 40 as of July
2014.
Regarding the Country of origin of the manuscripts
published in the Journal (Table 2), the majority are from
Canada, perhaps not surprisingly, with USA the second
highest contributing country. It is rather striking how
few submissions and publications are from the UK. This
area probably needs more attention. Perhaps this reflects
the small number of Allergy & Clinical Immunology
training programs in the UK and the fact they have their
own journal, Clinical & Experimental Allergy. The UK is
still third on the list of page visits.
Citations have also increased since joining BioMed
Central, from <10 in 2009 to 240 in 2013, an indication
of the growing interest in articles published in the
Journal.
In terms of citations, it appears that guidelines are
more frequently cited than other manuscripts, although
we do not have information on the citation of our Pri-
mer on Allergy & Immunology which was published as a
supplement. Articles in that supplement are among our
most highly accessed.
When we compare highly accessed articles all time
with those accessed in the last month (Table 3), there is
a significant change in the article types, with a much
higher proportion of manuscripts that are research arti-
cles being highly accessed, rather than reviews or guide-
lines, which is probably to be expected.
AACI has also been successful in its publication of
supplements. In addition to the yearly supplement
containing abstracts from the Annual Meeting of the
Canadian Society of Allergy & Clinical Immunology, we
also publish abstracts from the Allergen NCE Inc. An-
nual Meeting, recently held in conjunction with the
CSACI Meeting. This extremely valuable collaboration
enhances and expands the basic science interest in the
Annual Meeting and facilitates interactions between
basic scientists, clinician scientists and clinicians.
A second successful contribution by AACI has been in
the form of an educational supplement providing reviewCentral Ltd. This is an Open Access article distributed under the terms of the
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able for Medical School teaching and the education of
non-specialist physicians. The articles in this supplement
have also been among the most accessed publications in
AACI. This emphasizes the strong educational value of
the open access system particularly as the cost of text-
books in Allergy & Immunology increases progressively.
A third successful source of information in AACI is
in the form of guidelines for the treatment and man-
agement of allergic and immunologic disease. Some
frequently accessed examples of these guidelines are
provided in Table 1.Table 2 Country of origin of publication since 2009








Others 44Reviewing data from Google Analytics, the number of
page views per month has increased progressively to
34,660 in the month of July. Of these, 15,112 were
unique visitors, while new visitors are typically about
20% of all visits. Of these, the majority are from the
United States, followed by Canada, India and the United
Kingdom. The number of new visitors is encouraging
with regard to the increasing visibility of the Journal and
interest in its content. Approximately 12,000 sessions
originate from Google searches, compared to 189 from
Bing and 143 from Yahoo. Two thousand one hundred
and twenty visits were direct and 668 were from BioMed
Central. The latter had the greatest number of page ses-
sion, at 5.15, compared to 1.66 from Google and 1.59
from PubMed. Direct visits, most likely from return visi-
tors, viewed 2.48 pages per session. These data are inter-
esting in terms of the methods of access to the journal,
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visitors who come direct to the Journal or through
BioMed Central.
In this, our 10th year of publication, we would like to
thank the Co-editors of AACI, the Editorial Board, who
have worked hard to make the Journal a success, and
the many reviewers who have contributed their time and
expertise.
In addition, we thank the Canadian Society of Allergy
& Clinical Immunology, the Executive and Board and
Management team without whose support, both finan-
cial and by their contributions to the Journal; we would
not have achieved this success.
Finally, we must thank the many staff at BioMed Central
that have contributed to our success. A special thanks to
Lisa Hussey and Holly Young, who have guided the Journal
through the last several years successfully.
When AACI first began publishing in 2004, our goal
was to publish high quality research and review manu-
scripts, with the aim of eventually achieving indexing in
PubMed, Current Contents etc. Our manuscripts were
then by invitation only. Since joining BioMed Central,
we have achieved the aim of indexing, including now
Science Citation Index Expanded, and are awaiting our
first official Impact Factor from Thompson Reuters.
What we wish to achieve in the next 10 years is a steady
increase in the number and quality of submissions, so
that we can enhance the international reputation of our
journal and Society. This can be achieved by taking ad-
vantage of the tremendous advances in our understand-
ing of allergic and immunologic diseases and the new
treatments that have become available. This knowledge
can be widely disseminated by the important medium of
Open Access.
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